substitution for "narrow therapeutic index" (NTI) drugs

    The new generic warfarin is raising a big controversy about substitution for "narrow therapeutic index" (NTI) drugs.

    It's true some drugs have a narrow range between doses that are subtherapeutic...and doses that are toxic. Warfarin is one.

    There are others...carbamazepine...digoxin...levothyroxine...phenytoin...theophylline.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote